These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 27634342)
1. The publishing and patenting strategies of successful university spinoffs in the biopharmaceutical industry. Erden Z Drug Discov Today; 2017 Jan; 22(1):5-9. PubMed ID: 27634342 [TBL] [Abstract][Full Text] [Related]
2. The Idea of Patents vs. the Idea of University. de Campos TC New Bioeth; 2015; 21(2):164-76. PubMed ID: 27124964 [TBL] [Abstract][Full Text] [Related]
3. The roles of patents and research and development incentives in biopharmaceutical innovation. Grabowski HG; DiMasi JA; Long G Health Aff (Millwood); 2015 Feb; 34(2):302-10. PubMed ID: 25646111 [TBL] [Abstract][Full Text] [Related]
4. A perfect storm for innovation. Williams RN Clin Pharmacol Ther; 2010 Jul; 88(1):23; author reply 23-4. PubMed ID: 20445532 [No Abstract] [Full Text] [Related]
5. Biopharmaceutical innovation and industrial developments in South Korea, Singapore and Taiwan. Hsieh CR; Löfgren H Aust Health Rev; 2009 May; 33(2):245-57. PubMed ID: 19563313 [TBL] [Abstract][Full Text] [Related]
6. Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators. Rezaie R; McGahan AM; Frew SE; Daar AS; Singer PA Health Res Policy Syst; 2012 Jun; 10():18. PubMed ID: 22672351 [TBL] [Abstract][Full Text] [Related]
7. Research interactions between industry and academia: a corporate perspective. Citron P Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116 [No Abstract] [Full Text] [Related]
8. Investigating investment in biopharmaceutical R&D. Carter PH; Berndt ER; DiMasi JA; Trusheim M Nat Rev Drug Discov; 2016 Oct; 15(10):673-4. PubMed ID: 27616295 [TBL] [Abstract][Full Text] [Related]
9. Biotech patents-business as usual? Lawrence S Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861 [No Abstract] [Full Text] [Related]
10. With the help of a foreign ally: biopharmaceutical innovation in India after TRIPS. Angeli F Health Policy Plan; 2014 May; 29(3):280-91. PubMed ID: 23558959 [TBL] [Abstract][Full Text] [Related]
11. Strategic R&D transactions in personalized drug development. Makino T; Lim Y; Kodama K Drug Discov Today; 2018 Jul; 23(7):1334-1339. PubMed ID: 29574213 [TBL] [Abstract][Full Text] [Related]
14. Property rights go East. Nature; 2005 Nov; 438(7067):420-1. PubMed ID: 16306959 [No Abstract] [Full Text] [Related]
15. Ownership of knowledge--the role of patents in pharmaceutical R&D. Correa CM Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801 [TBL] [Abstract][Full Text] [Related]
16. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective. Närhi M; Nordström K Eur J Pharm Biopharm; 2005 Apr; 59(3):397-405. PubMed ID: 15760720 [TBL] [Abstract][Full Text] [Related]
18. [Publication ethics: regulation of financial conflicts of interests in medical journals]. Kakuk P Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379 [No Abstract] [Full Text] [Related]
19. Patenting nanotechnology. Lemley MA Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838 [TBL] [Abstract][Full Text] [Related]
20. Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged. Levy MS Am Univ Law Rev; 2016; 66(1):247-303. PubMed ID: 28225582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]